3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
213
Lung Neoplasms
79
Triple Negative Breast Neoplasms
67
Breast Neoplasms
67
Ovarian Neoplasms
56
Squamous Cell Carcinoma of Head and Neck
49
Small Cell Lung Carcinoma
47
Fallopian Tube Neoplasms
37
Endometrial Neoplasms
34
Neoplasms
31
Parkinson Disease 4, Autosomal Dominant Lewy Body
28
Neoplasm Metastasis
28
Head and Neck Neoplasms
24
Prostatic Neoplasms
20
Carcinoma
19
Esophageal Neoplasms
18
Urinary Bladder Neoplasms
16
Colorectal Neoplasms
16
Uterine Cervical Neoplasms
15
Oropharyngeal Neoplasms
14
Carcinoma, Transitional Cell
14
Carcinoma, Squamous Cell
14
Esophageal Squamous Cell Carcinoma
13
Brain Neoplasms
12
Stomach Neoplasms
10
Pancreatic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
10
Mouth Neoplasms
9
Laryngeal Neoplasms
9
Carcinoma, Ovarian Epithelial
9
Interventions
Cyclophosphamide
53
Vincristine
33
blinatumomab
30
Prednisone
28
Methotrexate
28
Cytarabine
26
Dexamethasone
24
Specimen Handling
21
Rituximab
21
Doxorubicin
20
merphos
19
Mercaptopurine
19
Etoposide
18
prednylidene
17
fludarabine
17
deltacortene
17
Calcium Dobesilate
17
Biopsy
17
dexamethasone acetate
16
dexamethasone 21-phosphate
16
auricularum
16
N,N-dicyclohexyl-isoborneol-10-sulfonamide
16
azathiopurine
15
Inotuzumab Ozogamicin
15
pegaspargase
14
venetoclax
13
Leucovorin
13
CT-P10
13
Asparaginase
13
Spinal Puncture
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Burkitt Lymphoma
×
Carboplatin
×
1 year
×
Clear all
NCT02393157
2025-08-08
O-ICE
New York Medical College
Phase 2
Recruiting
25 enrolled